EUROPE

Part of the company is focused on developing new medicines

GLOBAL STRATEGY Historically , the business has been strongly focused on the production of generic drugs but more recently has been building its branded portfolio with and growing its business through seven branded therapeutic areas of focus .

New Allergan is focused on developing new medicines that address unmet medical needs in critical therapeutic areas as well as increasing access to high-quality affordable medicines .

This year the company has invested significantly in Research & Development focusing on developing innovative and durable valueenhancing products within brands , generics , biologics and OTC ( Over the Counter ) portfolios .

The massive growth of the company through its acquisitive nature meant that while it was

www . allergan . com 61